Saccharomyces boulardii induced sepsis: successful therapy with voriconazole after treatment failure with fluconazole
Clicks: 308
ID: 265682
2005
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This
article has not been analysed, so there is no overall score —
reader engagement is measured and shown alongside.
Reader Engagement
Emerging Content
30.0
/100
308 views
34 readers
AI Quality Assessment
Not analyzed
Readership in this journal
EmergingRanked #9 of 11 articles by views in scandinavian journal of infectious diseases
Most read
Least read
Bar heights use a square-root scale.
Mint this article as an NFT
Not yet mintedCreate a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.
5
SUSD
one-off · no wallet required
Abstract
Saccharomyces boulardii is frequently used for prevention and treatment of all forms of diarrhoea. We report the case of a 19-y-old white male with an underlying severe neurological disease, who developed a fungal sepsis after prophylactic application of a drug containing S. boulardii. Initial treat …
Abstract Quality Issue:
This abstract appears to be incomplete or contains metadata (45 words).
Try re-searching for a better abstract.
| Reference Key |
o2005scandinaviansaccharomyces
Use this key to autocite in the manuscript while using
SciMatic Manuscript Manager or Thesis Manager
|
|---|---|
| Authors | Burkhardt O;Köhnlein T;Pletz M;Welte T;; |
| Journal | scandinavian journal of infectious diseases |
| Year | 2005 |
| DOI |
DOI not found
|
| URL | |
| Keywords |
National Center for Biotechnology Information
NCBI
NLM
MEDLINE
review
humans
pubmed abstract
nih
national institutes of health
national library of medicine
treatment outcome
adult
female
male
case reports
aged
middle aged
Child
Infant
sepsis / drug therapy*
sepsis / microbiology
voriconazole
antifungal agents / therapeutic use*
pyrimidines / therapeutic use*
triazoles / therapeutic use*
pmid:15764194
doi:10.1080/00365540510026454
olaf burkhardt
thomas köhnlein
tobias welte
fluconazole / therapeutic use*
saccharomyces / pathogenicity*
sepsis / physiopathology
|
Citations
No citations found. To add a citation, contact the admin at info@scimatic.org
Comments
No comments yet. Be the first to comment on this article.